Intelligence Β· Clinical Pipeline
AstraZeneca Pipeline
All ClinicalTrials.gov programs at AstraZeneca β phase, modality, and trial IDs.
- Programs
- 6
Quick answer
AstraZeneca has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
AZD1222
AstraZeneca
COVID-19, SARS-CoV-2
1 trial -
Dapagliflozin
AstraZeneca
Diabetes Mellitus, Type 2
1 trial -
Durvalumab
AstraZeneca
Solid Tumor
1 trial -
IMFINZI 50 mg/mL concentrate for solution for infusion., Lynparza 100 mg film-coated tablets, Lynparza 150 mg film-coated tablets
AstraZeneca
Advanced or recurrent endometrial cancer
1 trial -
Symbicort Turbuhaler (budesonide/formoterol) 320/9 ΞΌg
AstraZeneca
Chronic Obstructive Pulmonary Disease (COPD)
1 trial -
Symbicort Turbuhaler 160/4.5
AstraZeneca
Asthma
1 trial
Frequently asked questions
How many pipeline programs does AstraZeneca have?
6 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources Β· All pipeline programs